N-Acetyltransferase 1 genetic polymorphism, cigarette smoking, well- done meat intake, and breast cancer risk

Cancer Epidemiology Biomarkers and Prevention

Volumn 8, Issue 3, 1999, Pages 233-239

  Zheng, W ^a   Deitz, A C ^a   Campbell, D R ^a   Wen, W Q ^a   Cerhan, J R ^a   Sellers, T A ^a   Folsom, A R ^a   Hein, D W ^a  

^a UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER RISK; CIGARETTE SMOKING; CONTROLLED STUDY; FEMALE; FOOD COMPOSITION; GENE FREQUENCY; GENETIC POLYMORPHISM; HUMAN; MAJOR CLINICAL STUDY; MEAT; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

AGED; ALLELES; AMINES; ARYLAMINE N-ACETYLTRANSFERASE; BREAST; BREAST NEOPLASMS; CARCINOGENS; CASE-CONTROL STUDIES; COHORT STUDIES; CONFIDENCE INTERVALS; COOKERY; DNA; FEMALE; FOOD HABITS; GENE FREQUENCY; HUMANS; IOWA; ISOENZYMES; MEAT; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; POLYMORPHISM, GENETIC; POSTMENOPAUSE; PROSPECTIVE STUDIES; RISK FACTORS; SMOKING;

EID: 0032958158     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Ohgaki, H., Takayama, S., and Sugimura, T. Carcinogenicities of heterocyclic amines in cooked food. Mutat. Res., 259: 399-410, 1991.
2. Nagao, M., Ushijima, T., Wakabayashi, K., Ochiai, M., Kushida, H., Sugimura, T., Hasegawa, R., Shirai, T., and Ito, N. Dietary carcinogens and mammary carcinogenesis. Cancer (Phila.), 74: 1063-1069, 1994.
3. Ito, N., Hasegawa, R., Sano, S., Tamano, S., Esumi, H., Takayama, S., and Sugimura, T. A new colon and mammary carcinogen in cooked food, 2-amino-1-methyl-6-phenylimidazo[4,5b]pyridine (PhIP). Carcinogenesis (Lond.), 12: 1503-1506, 1991.
4. Shirai, T., Tamano, S., Sano, M., Masui, T., Hasegawa, R., and Ito, N. Carcinogenicity of 2-amino-1-methyl-6-phenylimidazo[4,5b]pyridine (PhIP) in rats: dose response studies. In: R. Adamson, J. A. Gustafsson, N. Ito, M. Nagao, T. Sugimura, K. Wakabayashi, and Y. Yamazoe (eds.), Heterocyclic amines in cooked foods: possible human carcinogens. Princeton, NJ: Princeton Scientific Publication Co., Inc., 1993.
5. Adamson, R. H. Mutagens and carcinogens formed during cooking of foods and methods to minimize their formation. In: V. T. Devita, Jr., S. Hellman, and S. A. Rosenberg (eds.), Cancer Prevention, pp. 1-7. Philadelphia, PA: J. B. Lippincott, 1990.
6. Layton, D. W., Bogen, K. T., Knize, M. G., Hatch, F. T., Johnson, V. M., and Felton, J. S. Cancer risk of heterocyclic amines in cooked foods: an analysis and implications for research. Carcinogenesis (Lond.), 16: 39-52, 1995.
7. Vineis, P. Epidemiology of cancer from exposure to arylamincs. Environ. Health Perspect., 106 (Suppl. 6): 7-10, 1994.
8. Sinha, R., and Rothman, N. Exposure assessment of heterocyclic amines (HCAs) in epidemiologic studies. Mutat. Res., 376: 195-202, 1997.
9. Zheng, W., Gustafson, D. R., Sinha, R., Cerhan, J. R., Moore, D., Hong, C. P., Anderson, K. E., Kushi, L. H., Sellers, T. A., and Folsom, A. R. Well-done meat intake and the risk of breast cancer. J. Natl. Cancer Inst. (Bethesda), 90: 1724-1729, 1998.
10. Knekt, P., Steineck, G., Järvinen, R., Hakulinen, T., and Aromaa, A. Intake of fried meat and risk of cancer: a follow-up study in Finland. Int. J. Cancer, 59: 756-760, 1994.
11. Phillips, R. L. Role of life-style and dietary habits in risk of cancer among Seventh-Day Adventists. Cancer Res., 35: 3513-3522, 1975.
12. Iscovich, J. M., Iscovich, R. B., Howe, G., Shiboski, S., and Kaldor, J. M. A case-control study of diet and breast cancer in Argentina. Int. J. Cancer, 44: 770-776, 1989.
13. Matos, E. L., Thomas, D. B., Sobel, N., and Vuoto, D. Breast cancer in Argentina: a case-control study with special reference to meat-eating habits. Neoplasma, 38: 357-366, 1991.
14. De Stefani, E., Ronco, A., Mendilaharsu, M., Guidobono, M., and Deneo-Pellegrini, H. Meat intake, heterocyclic amines, and risk of breast cancer: a case-control study in Uruguay. Cancer Epidemiol. Biomark. Prev., 6: 573-581, 1997.
15. Palmer, J., and Rosenberg, L. Cigarette smoking and breast cancer. Epidemiol. Rev. 15: 145-162, 1993.
16. Baron, J., Newcomb, P., Longnecker, M., Mittendorf, R., Storer, B., Clapp, R., Bogdan, G., and Yuen, J. Cigarette smoking and breast cancer. Cancer Epidemiol. Biornark. Prev., 5: 399-405, 1996.
17. Morabia, A., Bernstein, M., Héritier, S., and Khatchatrian, N. Relation of breast cancer with passive and active exposure to tobacco smoke. Am. J. Epidemiol., 143: 918-928, 1996.
18. Brunet, J. S., Ghadirian, P., Rebbeck, T. R., Lerman, C., Garber, J. E., Tonin, P. N., Abrahamson, J., Foulkes, W. D., Daly, M., Wagner-Costalas, J., Godwin, A., Olopade, O. I., Moslehi, R., Liede, A., Futreal, P. A., Weber, B. L., Lenoir, G. M., Lynch, H. T., and Narod, S. A. Effects of smoking on breast cancer in carriers of mutant BRCA1 or BRCA2 genes. J. Natl. Cancer Inst. (Bethesda), 90: 761-765, 1998.
19. Gammon, M. D., Scoenberg, J. B., Teitelbaum, S. L., Brinton, L. A., Potischman, N., Swanson, C. A., Brogan, D. J., Malone, K. E., and Stanford, J. L. Cigarette smoking and breast cancer risk among young women. Am. J. Epidemiol., 147 (Suppl.): S93, 1998.
20. Ambrosone, C. B., Freudenheim, J. L., Graham, S., Marshall, J., Vena, J., Brasure, J., Michalek, A., Laughlin, R., Nemoto, T., Gillenwater, K., Harrington, A., and Shields, P. Cigarette smoking, N-acetyltransferase 2 genetic polymorphisms and breast cancer risk. J. Am. Med. Assoc., 276: 1494-1501, 1996.
21. Hunter, D., Hankinson, S., Hough, H., Gertig, D., Garcia-Closas, M., Spiegelman, D., Manson, J., Colditz, G., Willet, W., Speizer, F., and Kelsey, K. A prospective study of NAT2 acetylation genotype, cigarette smoking and risk of breast cancer. Carcinogenesis (Lond.), 18: 2127-2132, 1997.
22. Morabia, A., Bernstein, M., Héritier, S., Bourchardy, I., and Morris, M. A. NAT2-smoking interaction with respect to breast cancer in menopausal women. Am. J. Epidemiol., 147 (Suppl.): S45, 1998.
23. Zheng, W., Gross, M., Campbell, D., Mink, P., Cerhan, J. R., Kushi, L., Sellers, T., Anderson, K., Oetting, W., and Folsom, A. R. Polymorphisms of the NAT2, CYPIA1, and GSTM1 genes and the risk of breast cancer. Pezcoller Found. J., 29, 1998.
24. Hein, D. W., Doll, M. A., Rustan, T. D., Gray, K., Feng, Y., Ferguson, R. J., and Grant, D. M. Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferases. Carcinogenesis (Lond.), 14: 1633-1638, 1993.
25. Minchin., R. F., Kadlubar, F. F., and Ilett, K. F. Role of acetylation in colorectal cancer. Mutat. Res., 290: 35-42, 1993.
26. Hein, D. W. Acetylator genotype and arylamine-induced carcinogenesis. Biochim. Biophys. Acta, 948: 37-66, 1988.
27. Weber, W. W., and Hein, D. W. N-Acetylation pharmacogenetics. Pharmacol. Rev., 37: 25-79, 1985.
28. Vatsis, K. P., Weber, W. W., Bell, D. A., Dupret, J. M., Price-Evans, D. A., Grant, D. M., Hein, D. W., Lin, H. J., Meyer, U. A., Relling, M. V., Sim, E., Suzuki, T., and Tamazoe, Y. Nomenclature for N-acetyltransferases. Pharmacogenetics, 5: 1-17, 1995.
29. Vatsis, K. P., and Weber, W. W. Structural heterogeneity of Caucasian N-acetyltransferase at the NAT1 gene locus. Arch. Biochem. Biophys., 301: 71-76, 1993.
30. Minchin, R. F., Reeves, P. T., Teitel, C. H., McManus, M. E., Mojarrabi, B., Ilett, K. F., and Kadlubar, F. F. N-and O-acetylation of aromatic and heterocyclic amine carcinogens by human monomorphic and polymorphic acetyltransferases expressed in COS-1 cells. Biochem. Biophys. Res. Commun., 185: 839-844, 1992.
31. Hein, D. W., Rustan, T. D., Ferguson, R. J., Doll, M. A., and Gray, K. Metabolic activation of aromatic and heterocyclic N-hydroxyarylamines by wild-type and mutant recombinant human NAT1 and NAT2 acetyltransferases. Arch. Toxicol., 68: 129-133, 1994.
32. Hein, D. W., Doll, M. A., Rustan, T. D., and Ferguson, R. J. Metabolic activation of N-hydroxyarylamines and N-hydroxyarylamides by 16 recombinant human NAT2 allozymes: effects of seven specific NAT2 nucleic acid substitutions. Cancer Res., 55: 3531-3536, 1995.
33. Millikan, R. C., Pittman, G. S., Newman, B., Tse, C-K. J., Selmin, O., Rockhill, B., Savitz, D., Moorman, P. G., and Bell, D. A. Cigarette smoking, N-acetyltransferases 1 and 2, and breast cancer risk. Cancer Epidemiol, Biomark. Prev., 7: 371-378, 1998.
34. Sadrieh, N., Davis, C. D., and Snyderwine, E. G. N-acetyltransferase expression and metabolic activation of food-derived heterocyclic amines in the human mammary gland. Cancer Res., 56: 2683-2687, 1996.
35. Bell, D. A., Stephens, E. A., Castranio, T., Umbach, D. M., Watson, M., Deakin, M., Elder, J., Jendrickse, C., Duncan, H., and Strange, R. C. Polyadenylation polymorphism in the acetyltransferase 1 gene (NAT1) increases risk of colorectal cancer. Cancer Res., 55: 3537-3542, 1995.
36. Taylor, J. A., Umbach, D., Stephens, E., Paulson, D., Robertson, D., Mohler, J., and Bell, D. A. The role of N-acetylation polymorphisms at NAT1 and NAT2 in smoking-associated bladder cancer. Proc. Am. Assoc. Cancer Res., 36: 1681, 1995.
37. Kushi, L. H., Sellers, T. A., Potter, J. D., Nelson, C. L., Munger, R. G., Kaye, S. A., and Folsom, A. R. Dietary fat and postmenopausal breast cancer. J. Natl. Cancer Inst. (Bethesda), 84: 1092-1099, 1992.
38. Folsom, A. R., Kaye, S. A., Sellers, T. A., Hong, C. P., Cerhan, J. R., Potter, J. D., and Prineas, R. J. Body fat distribution and 5-year risk of death in older women. J. Am. Med. Assoc., 269: 483-487, 1993.
39. Bisgard, K. M., Folsom, A. R., Hong, C. P., and Sellers, T. A. Mortality and cancer rates in non-respondents to a prospective study of older women: 5-year follow-up. Am. J. Epidemiol., 139: 990-1000, 1994.
40. Deitz, A. C., Doll, M. A., and Hein, D. W. A restriction fragment length polymorphism assay that differentiates human N-acetyltransferase-1 (NAT1) alleles. Anal. Biochem., 253: 319-324, 1997.
41. Butcher, N. J., Ilett, K. F., and Minchin, R. F. Functional polymorphism of the human arylamine N-acetyltransferase type 1 gene caused by C190T and G560A mutations. Pharmacogenetics, 8: 67-72, 1998.
42. Lin, H. J., Probst-Hensch, N. M., Hughes, N. C., Sakamoto, G. T., Louie, A. D., Kau, I. H., Lin, B. K., Lee, D. B., Lin, J., Frankl, H. D., Lee, E. R., Hardy, S., Grant, D. M., and Haile, R. W. Variants of N-acetyltransferase NAT1 and a case-control study of colorectal adenomas. Pharmacogenetics, 8: 269-281, 1998.
43. Abdel-Rahman, S. Z., El-Zein, R. A., Zwishchenberger, J. B., and Au, W. W. Association of the NAT1*10 genotype with increased chromosome aberrations and higher lung cancer risk in cigarette smokers. Mutat. Res., 398: 43-54, 1998.
44. Olshan, A., Watson, M. A., Smith, J., Wiessler, M., and Bell, D. A. Association of N-acetyltransferase 1 (NAT1) genotype and smoking with risk of head and neck cancers. Proc. Am. Assoc. Cancer Res., 8: 331, 1997.
45. Katoh, T., and Bell, D. A. The role of N-acetylation polymorphisms (NAT1 and NAT2) in gastric and colorectal adenomas. Proc. Am. Assoc. Cancer Res., 38: 619, 1997.
46. Grant, D. M., Hughes, N., Janezic, S., Goodfellow, G., Chen, H., Gaedigk, A., Yu, V., and Grewal, R. Human acetyltransferase polymorphisms. Mutat. Res., 376: 61-70, 1997.
47. Bell, D. A., Badawi, A. F., Lang, N. P., Ilett, K. F., Kadlubar, F. F., and Hirvonen, A. Polymorphism in the N-acetyltransferase 1 (NAT1) polyadenylation signal: association of NAT1*10 allele with higher N-acetylation activity in bladder and colon tissue. Cancer Res., 55: 5226-5229, 1995.
48. Badawi, A. F., Hirvonen, A., Bell, D. A., Lang, N. P., and Kadlubar, F. F. Role of aromatic amine acetyltransferases, NAT1 and NAT2, in carcinogen-DNA adduct formation in the human urinary bladder. Cancer Res., 55: 5230-5237, 1995.
49. Anderson, K. E., Hammons, G. J., Kadlubar, F. F., Potter, J. D., Kaderlik, K. R., Ilett, K. F., and Minchin, R. F. Metabolic activation of aromatic amines by human pancreas. Carcinogenesis (Lond.), 18: 1085-1092, 1997.
50. Hickman, D., Pope, J., Patil, S. D., Fakis, G., Smelt, V., Stanley, L. A., Payton, M., Unadkat, J. D., and Sim, E. Expression of arylamine N-acetyltransferase in human intestine. Gut, 42: 402-409, 1998.
51. Hughes, N. C., Janezic, S. A., McQueen, K. L., Jewett, M. A. S., Castranio, T., Bell, D. A., and Grant, D. M. Identification and characterization of variant alleles of human acetyltransferase NAT1 with defective function using p-aminosalicylate as an in-vivo and in-vitro probe. Pharmacogenetics, 8: 55-66, 1998.
52. Feng, Y., Rustan, T. D., Doll, M. A., Leff, M. A., Cooley, A. M., Fretland, A. J., Gruzziotin, M. U., Luthra, E., Becker, W. K., and Hein, D. W. Human N-acetyltransferase-1 (NAT1) and -2 (NAT2) genotype/phenotype determinations in cytosolic preparations from surgical human colon specimens. In: Proceedings of the First International Workshop on the Arylamine N-Acetyltransferases, p. 23. Kuranda, Queensland, Australia: 1998.
53. de Leon, J. H., Vatsis, K. P., and Weber, W. W. Catalytic activities of human N-acetyltransferase (NAT1) variants expressed in COS-1 cells. FASEB J., 10: A456, 1996.
54. Doll, M. A., Jiang, W., Deitz, A. C., Rustan, T. D., and Hein, D. W. Identification of a novel allele at the human NAT1 acetyltransferase locus. Biochem. Biophys. Res. Commun., 233: 584-591, 1997.
55. Johnson, K. C., Semenciw, R., H, J., Mao, Y., and the Canadian Cancer Registries Epidemiology Research Group. Active and passive smoking and premenopausal breast cancer. Am. J. Epidemiol., 147 (Suppl.): S68, 1998.
56. Kohlmeier, L., DeMarini, D., and Piegorsch, W. Gene-nutrient interactions in nutritional epidemiology. In: B. M. Margetts and M. Nelson (eds.), Design Concepts in Nutritional Epidemiology, pp. 312-337. Oxford, UK: Oxford, Press, 1997.